Skip to main content
Canna~Fangled Abstracts

Intra-Testicular Signals Regulate Germ Cell Progression and Production of Qualitatively Mature Spermatozoa in Vertebrates

By May 8, 2014No Comments
pub med big
Logo of frontendo

Front Endocrinol (Lausanne). 2014; 5: 69. 
Published online May 8, 2014. doi:  10.3389/fendo.2014.00069
PMCID: PMC4021137

Intra-Testicular Signals Regulate Germ Cell Progression and Production of Qualitatively Mature Spermatozoa in Vertebrates

Abstract

Spermatogenesis, a highly conserved process in vertebrates, is mainly under the hypothalamic–pituitary control, being regulated by the secretion of pituitary gonadotropins, follicle stimulating hormone, and luteinizing hormone, in response to stimulation exerted by gonadotropin releasing hormone from hypothalamic neurons. At testicular level, gonadotropins bind specific receptors located on the somatic cells regulating the production of steroids and factors necessary to ensure a correct spermatogenesis. Indeed, besides the endocrine route, a complex network of cell-to-cell communications regulates germ cell progression, and a combination of endocrine and intra-gonadal signals sustains the production of high quality mature spermatozoa. In this review, we focus on the recent advances in the area of the intra-gonadal signals supporting sperm development.

Keywords: testis, spermatogenesis, GnRH, kisspeptins, estrogens, sperm quality, spermatozoa

Introduction

In vertebrates, spermatogenesis is a hormonally controlled mechanism charged to produce gametes useful for reproduction. The production of high standard quality gametes is the main goal to preserve reproduction.

Spermatogenesis develops as a process consisting of mitotic, meiotic, and differentiation steps promoting germ cell progression from spermatogonia-to-spermatozoa (SPZ). In male, the hypothalamus–pituitary–gonadal axis supports germ cell progression, via gonadotropin releasing hormone (GnRH)–gonadotropin–steroid production and its activity is finely regulated by positive and negative feedbacks. Furthermore, a network of intra-gonadal factors, organized in a complex stage-specific multi-factorial net, is responsible for spermatogenesis control (1).

Using a comparative approach, this review summarizes the intriguing and sometimes conflicting information about the intra-testicular role played by GnRH, Kisspeptin, and estrogens in germ cell progression and production of high standard quality sperm.

GnRH, a Historical Modulator of Testis Physiology

The GnRH, crucial player of the neural control of vertebrate reproduction, was originally isolated from the hypothalamus of pig and sheep (2). Basically, GnRH stimulates the synthesis and the discharge of pituitary gonadotropins [follicle stimulating hormone and luteinizing hormone (FSH and LH), respectively], which in turn induce both gametogenesis and the production of gonadal steroids. At present, 25 GnRH forms have been identified in protochordates and vertebrates (34) and in many vertebrates three GnRH molecular forms have been identified: GnRH-1, GnRH-2, and GnRH-3 (formerly known as mammalian, chicken-II, and salmon GnRH, respectively) (3). GnRH action is mediated through high-affinity binding with the GnRH receptor (GnRH-R) (56), a rhodopsin-like seven trans-membrane G protein-coupled receptor (GPCR). In vertebrates, GnRH-Rs exhibit a wide range of subtypes and alternate splicing derived forms (1357). The presence of multiple forms of GnRHs and GnRH-Rs in the brain, with specific expression profiles, suggests the existence of different functional roles: in fact, GnRH-1 is considered the final regulator of the pituitary–gonadal axis; GnRH-2 is supposed to play a function for the control of sexual behavior, food intake, energy balance, stress, and many other environmental cues; GnRH-3, found only in the telencephalon of teleost fish, probably acts as neuro-modulator (138).

Extrahypothalamic synthesis and function of GnRHs and GnRH-Rs have been detected in many reproductive tissues in vertebrates, including human (gonads, prostate, endometrial tissue, oviduct, placenta), and in cancer cells (15911).

GnRH plays several conserved roles in testis physiology, being the main paracrine modulator of the Leydig–Sertoli, Sertoli–germ cell, Sertoli–peritubular cell communications (112). In this context, it drives steroidogenesis, germ cells progression, and acquisition of SPZ functions (11215).

The demonstration of a direct GnRH effect on testis has been provided in fish, frog, rodent, and human Leydig cells showing GnRH-specific high-affinity binding sites (131516). The finding of GnRHmRNA in Sertoli and spermatogenic cells in different species (17) suggests its involvement in paracrine Leydig–Sertoli cell communication (12). A similar pattern of expression has been confirmed in human (17), expressing two GnRH molecular forms and two GnRH-Rs (1819). However, the identification of GnRH-R2 antisense transcript in human testis (20) and the presence of frame-shift mutations and stop codons in human GnRH-R2 (5) may indicate that these transcripts are not really functional.

The major reported effect of GnRH on vertebrate testis physiology concerns the modulation of steroidogenesis in in vivo and in vitro systems (12123). Interestingly, in elasmobranch and in dipnoi, this effect appears to be exerted trough the endocrine route (2425). Both GnRH-1 and GnRH-2 agonists have the ability to stimulate mouse pre-pubertal Leydig cell steroidogenesis, in a dose- and time-dependent manner, via transcriptional activation of 3β-hydroxy-steroid dehydrogenase (3β-HSD) (23). Accordingly, in human, the expression levels of GnRH-1GnRH-2GnRH-Rscytochrome P450 side-chain cleavage(CYP11A1), 3β-HSD type 2 enzyme, and the intra-testicular testosterone (T) levels are significantly increased in patients with spermatogenic failure (26). At molecular level, the transduction pathway involving the GnRH agonist-dependent activation of ERK1/2 has been reported (27). Interestingly, in mouse testis, GnRH-R activity well correlates with the increased steroidogenic activity observed during pubertal and adult stages and its decline parallels the decreased steroidogenic activity observed during the senescence (28). These expression profiles are consistent with the increasing expression of the gonadotropin inhibitory hormone (GnIH) during senescence, providing evidences of local interaction between GnRH and GnIH. The testicular localization of GnIH and its receptor GPR147, in both mammals and birds, opens new perspectives in the autocrine/paracrine control of testicular activity suggesting a possible interplay between GnRH and GnIH in order to modulate T secretion and spermatogenesis (29). Furthermore, GnRH activity in Leydig cells is not restricted to T production but is extended to the development of rat progenitor Leydig cells both in vivo and in vitro (30).

Several studies, carried out in cancer cell lines, demonstrated a direct anti-proliferative/apoptotic effect of GnRH and its synthetic agonists (3132). Accordingly, GnRH activity is a well-known modulator of germ cell apoptosis during the regression of fish gonad (3334). In rodents, GnRH agonists stimulate spermatogenic colony formation following spermatogonia (SPG) transplantation (3536) and induce SPG proliferation in damaged testis (37). In mollusk, a scallop GnRH-like peptide stimulates SPG cell division (38). In amphibian, a GnRH agonist induces G1-S transition of SPG cell cycle (3943) whereas, in mouse, GnRH is expressed in gonocytes at birth (28). At molecular level, in the anuran amphibian Rana esculenta, SPG proliferation requires the cooperation between estradiol (E2) and GnRH, in a mechanism involving the E2-dependent transcriptional activation of c-fos (42) and a GnRH-mediated translocation of FOS protein from the SPG cytoplasm into the nucleus (43). Thus, GnRH activity may represent a key controller of proliferative/anti-proliferative events characteristic of testis renewal. Consistently, it has been found that GnRH induces proliferation of partially differentiated gonadotrope cells (44).

Lastly, the ability of GnRH agonists to induce spermiation (45) and the localization of GnRH and/or GnRH-Rs in spermatids (SPTs) and SPZ in mammalian and non-mammalian vertebrates (17284647) suggest the involvement of GnRH signaling in SPZ functions and fertilization. Accordingly, GnRH antagonists inhibit, in vivo and in vitro, fertilization in rodents (14) whereas sperm binding to the human zona pellucida and calcium influx in response to GnRH and progesterone have been reported (13), providing evidence of functional role of GnRH-Rs in human SPZ.

The above indicated intra-testicular activity of GnRH has been described in detail in the frog R. esculenta, a species showing a complex GnRH system, deeply characterized at testicular level (46). In this seasonal breeder, two GnRH molecular forms (GnRH-1 and GnRH-2) and three receptor forms (GnRH-R1, -R2, -R3) (48) with specific expression pattern and localization in testis during the annual reproductive cycle (46) have been identified. In situ hybridization suggests a different role for GnRH-1 and GnRH-2, as GnRH-1 and GnRH-R1 seem to be linked to germ cell progression and interstitial compartment activity, whereas GnRH-2 and GnRH-R2 seem to be linked to sperm function and release (46), confirming the hypothesis that each ligand might be involved in the modulation of specific processes. Interestingly, this functional portioning well correlates with the differential modulation of GnRH system counterparts exerted via the activation of endocannabinoid system, an evolutionarily conserved system deeply involved in central and local control of reproductive functions (4952). At central level, in mammals, endocannabinoids interfere with GnRH production (5354) and signaling (55). In frog diencephalons, they modulate the expression of GnRH-1/GnRH-2 (485657) – both hypophysiotropic factors (1), GnRH-R1and GnRH-R2 (48) (Figure (Figure1).1). Furthermore, in frog testis, the endocannabinoid anandamide (AEA), via type 1 cannabinoid receptor (CB1) activation, modulates testicular GnRH activity at multiple levels and in a stage-dependent manner (46) (Figure (Figure2).2). Interestingly, the activation of cannabinoid receptors other than CB1, such as the vanilloid transient receptor type 1 (TRPV1), differentially modulates the expression level of GnRHs/GnRH-Rs, but in an opposite manner as compared with CB1 (58). Thus, the transcriptional switch on/off of testicular GnRH system is finely toned through the activation of specific endocannabinoid receptors, providing evidence of a central role of this system in the local modulation of GnRH activity.

Figure 1

A schematic view of the effects of AEA incubation on GnRH-1(G1), GnRH-2 (G2), GnRH-R1 (R1), and GnRH-R2 (R2) expression in frog R. esculenta diencephalon. Animals were collected in June and testes were incubated in vitro for 1 h. Via CB1 activation, 
Figure 2

A schematic view of the effects of AEA treatment on GnRH-1(G1), GnRH-2 (G2), GnRH-R1 (R1), GnRH-R2 (R2), and GnRH-R3 (R3) expression in frog R. esculenta testis. Animals were collected in June (A) and February (B) and testes were incubated in vitro for 

Kisspeptins, Possible Players in Testis Physiology Currently Under Investigation

Kisspeptins are a novel class of neuro-peptides with a key position in the scenario of reproduction. They are encoded by the kiss1 gene, originally discovered as a metastasis-suppressor gene in 1996 (59), and they are initially produced as an unstable 145-amino acid precursor peptide (kp145), then cleaved into shorter peptides (kp-54, kp14, kp-13, and kp-10). Interestingly, all kisspeptin shorter peptides are biologically active due to the binding to the “kiss” receptor GPR54 (60). The primary targets of kisspeptins are just the hypothalamic GnRH-secreting neurons (61) and, similarly to the deletion/mutation of GnRH or GnRH-Rgenes, target disruption of both kiss1 and GPR54 leads to hypogonadotropic hypogonadism and lack of sexual maturation (6263). Accordingly, the administration of kisspeptins accelerates the timing of puberty onset in fish (6467) and mammals (6869), whereas circulating higher kisspeptin levels have been observed in clinical cases of precocious puberty in human (7071).

Several studies have been focused on the characterization of the kisspeptin-dependent signaling in the hypothalamus, with particular concern to the negative and the positive feedback action of sex steroids on kiss1 gene expression in the arcuate and the antero-ventral-preoptic nucleus, respectively [for review see Ref. (72)]. Therefore, in the last years, the idea that kisspeptin signaling is an essential guardian angel of reproduction, through the regulation of GnRH neurons, took place. These views strongly stride with evidences that genetic ablation of nearly all kisspeptin neurons does not impair reproduction, suggesting that possible compensatory mechanisms rescue reproduction (73). Probably, kisspeptin neurons and related products are in excess of what is really required to support reproductive functions. In this respect, male and female mice with a 95% reduction in kiss1 transcript levels are normal and sub-fertile, respectively. This suggests that an overproduction of kisspeptin represents a failsafe to guarantee reproductive success (74).

A novel chapter of kisspeptin saga concerns the possible intra-gonadal action of these molecules. Kiss1 and/or GPR54 have been observed in several peripheral tissues, gonads included. In particular, the presence of both ligand and receptor has been observed in the human placenta (75) and testis (6075) whereas GPR54 alone has been detected in mouse (76), rat (77), rhesus monkey (7879), and frog (80) testis. However, the functional mechanisms of kisspeptin/GPR54 system in gonads remain to be elucidated and several conflicting data concerning the direct involvement of kisspeptin activity in testis physiology emerged.

Long term kisspeptin-10 (kp-10) (81) and/or kp-54 (82) administration in maturing and adult rat testes gives rise to degenerative effects on spermatogenesis and suppresses the circulating levels of LH and T; no effects have been registered upon FSH levels. Specifically, germ cell number significantly decreases, many germ cells appear regressed, atrophied, and in necrosis; round and elongated SPTs show abnormal acrosome; intraepithelial vacuolization is visible, interstitial spaces are enlarged, and the germinal epithelium is irregularly shaped. Leydig cells frequently lose contacts with the seminiferous tubules and Sertoli–germ cell interaction is destroyed (81). A similar degenerative effect – caused by continuous administration of kp-10 – has also been discovered in rat seminal vesicles (83) and pre-pubertal prostate gland (84). Conversely, a physiological role of kisspeptins in testis has been completely excluded in mouse (85) and conflicting data concerning the localization of kiss1/GPR54 protein and mRNA recently emerged. The use of different antisera, strategies, and strains as well might be taken in account to explain these discrepancies and the missing overlapping in mRNA/protein detection described so far. In fact, in transgenic mice with LacZ targeted to either kiss1 or GPR54 genes, kiss1 and GPR54 mRNA have been localized in mouse round SPTs, whereas kisspeptin protein has been shown in Leydig cells, with no staining in SPTs (85). Conversely, both GPR54 and kiss1 immunoreactivity has been provided in both Leydig and germ cells (primordial germ cells and elongating SPTs) with significant age-related variations (28). Studies conducted in Leydig cell line MA-10 – a cell line that expresses LH receptors and responds to human chorionic gonadotropin (hCG) stimulation, producing progesterone as major steroid hormone – confirm that these cells produced GPR54 mRNA, but were unable to show any kiss1 expression (85). Despite GPR54 expression, from a functional point of view kp-10 does not exert any significant direct effects on steroid production in both MA-10 cell line or in physiological systems, such as mouse seminiferous tubule explants (85). However, evidences reported in other species examined so far, pointed out a possible role of kisspeptin system just in steroidogenetic activity. Although Leydig cells do not show any kisspeptin and/or GPR54 immuno-localization in rhesus monkey (78), intra-testicular action on steroidogenesis (79) has been demonstrated in monkeys treated with acyline, a GnRH-R antagonist (86), just to exclusively investigate kisspeptin activity without any influence of pituitary gonadotropic drive. In these clamped monkeys, kp-10 has a synergic effect with hCG to induce T production (79). Anyway, the real possible mechanism through which kisspeptin enhances T production in primates is not clear and may require additional paracrine routes involved in Leydig–Sertoli cell communications. In fact, in rhesus monkey kisspeptin immunoreactivity has been detected in spermatocytes (SPCs) and SPTs, whereas GPR54 has been localized in SPCs and Sertoli cells (78). Thus kisspeptin – produced by germ cells – might act in an autocrine/paracrine manner to control the progression of the spermatogenesis and/or to modulate Sertoli cells activity. It is noteworthy, however, that intravenous injection of the kisspeptin antagonist 234 (kp-234) (87) does not alter plasma T levels in adult rhesus monkey. Interestingly, Anjum and co-workers reported that kisspeptin expression – analyzed by slot blot analysis in Leydig cells of Parkes strain mice – significantly decreases from birth to pre-pubertal testis, increases during pubertal period, decreases in reproductive active mouse to further increase during the senescence. These expression profiles well correlate to GnIH expression and to the decreased steroidogenic activity observed during the senescence, providing evidence of a possible involvement of kisspeptin in the control of steroidogenesis in cooperation with testicular GnIH (28).

The detection of kiss1 and GPR54 mRNA in round/elongating SPTs (287885) raises the possibility that autocrine or paracrine kisspeptin actions might be involved in spermiogenesis and in the acquisition of sperm functions, as recently demonstrated in human SPZ by Candenas and co-workers (88). This group immunolocalized kisspeptin and GPR54 in the post-acrosome region of the human SPZ head and in the equatorial segment of the tail, providing also evidence of some regulatory actions. In fact, 1 μM kp-13 increases [Ca2+]i and induces a small, but significant change in sperm motility, leading to motility trajectories that characterize hyper-activated SPZ. Instead, the same treatment has no effect on acrosome reaction (88). Very recently, in mouse, GPR54 has been specifically localized in the acrosomal region of SPTs and mature SPZ whereas kisspeptin expression has been detected in the cumulus–oocyte complex and oviductal epithelium of ovarian and oviductal tissue (89). Since SPZ treatment with kp-234 decreases the in vitro fertilization rates, evidence emerged that kisspeptin modulates fertilization capability in mammals (89).

Interestingly, in sexually immature scombroid fish, kp-15 peripheral administration induced spermiation (67), accordingly to GPR54 expression detected in the myoid peritubular cells in amphibians (80), indicating a possible involvement in sperm transport and release.

Compelling evidence about gonadal activity of kisspeptin system recently comes from a non-mammalian vertebrate, the anuran amphibian, the frog R. esculenta. In this seasonal breeder, germ cell progression is under the control of endocrine, environmental, and gonadal factors (9091), whereas spermatogenesis proceeds in cysts, typical formations consisting of Sertoli cells enveloping cluster of germ cells at a synchronous stage (91). During the frog annual sexual cycle, GPR54 mRNA has been analyzed in testis, showing higher expression at the end of the winter stasis and during the breeding season (80). In these periods, in an E2-dependent fashion, the recruitment of SPG and the onset of a new spermatogenetic wave take place (429192). Consistently, in February, GPR54 mRNA has been revealed in primary and secondary SPG by in situ hybridization (Figure (Figure3)3) (80) accordingly to kisspeptin localization in primordial germ cells observed in mouse (28). In proliferating germ cells, a strong expression of GPR54 mRNA has been found in interstitial compartment of frog testis all over the annual sexual cycle (Figure (Figure3).3). Contrary to human, in frog post meiotic cells and SPZ do not express GPR54 mRNA, but it is not excluded that the GPR54 mRNA produced in SPG might be translated in later stages. Since E2 is likely to be involved in various aspects of testicular activity such as steroidogenesis and primary SPG proliferation (429395), a possible relationship between E2 and kisspeptin/GPR54 has been analyzed in frogs. In this respect, an E2-dependent modulation of GPR54 expression has been reported in testis. In addition, kp-10, in vitro, is able to modulate both GPR54 and ERα expression at the end of the winter stasis (February) as well as during the breeding season (March) (80). Therefore, via kisspeptins/GPR54 activation, E2 might regulate steroidogenic activity and SPG proliferation. This hypothesis is supported by the localization of GPR54mRNA that well correlates with the sites of E2 action occurring in frog testis (90). Thus, the expression of GPR54 inside the interstitium and in proliferating SPG, as well as its E2-dependent expression, strongly support the hypothesis that kisspeptin might have a direct involvement in the onset of the spermatogenetic wave. Accordingly, subcutaneous administration of kp-15 accelerates spermatogenesis in the pre-pubertal teleost Scomber japonicus without any significant change in the expression of hypothalamic GnRH-1 and pituitary FSHβ and LHβ subunits (66). In addition, kp-10 involvement in differentiation events has been further confirmed in the rhesus monkey derived stem cell line r366.4 (96).

Figure 3

Sections of R. esculenta testis, collected in February, analyzed by in situ hybridization for GPR54GPR54 mRNA was detected in the interstitial compartment (A,B), in primary spermatogonia (B), in secondary spermatogonia cysts (B) as well as in myoid 

It is evident that the several controversies regarding the “kisspeptin saga” make their history more intriguing with many “behind-the-scenes” yet to be written.

Estrogens and Sperm Quality

Traditionally, E2 is stereotyped as the “female” and T as the “male” hormone. E2 and T are instead present in both males and females, and in male the ratio between the two hormones controls reproduction via specific receptors (16). To date, nuclear (ERα and ERβ) and membrane-bound (GPR30) receptors, able to respond to E2 via genomic and non-genomic pathways, respectively, have been identified [for review see Ref. (9798)].

Estrogens are synthesized via the irreversible transformation of androgens by the aromatase (P450arom; Cyp19A1 is the related gene), an enzyme expressed in the endoplasmic reticulum of testicular cells. In male, E2 is indeed primarily synthesized in the testis, which expresses also the specific receptors, ERα and ERβ (16). Recently, GPR30 has been studied in fish, rat, and human and localized in somatic (rat and human) and germ (fish and rat) cells (99102).

P450arom and ERs expression has been studied in mammalian and non-mammalian testis and the specific mRNA and/or proteins localized in the interstitial (Leydig cells) and tubular (Sertoli and germ cells) compartments, depending on the species [for reviews see Ref. (11697103)], demonstrating that both somatic and germ cells are able to produce E2 that can act locally.

In vertebrates, E2 acts at both central (hypothalamus and hypophysis) (55104) and local (testis, efferent ductules, and epididymis) (1105106) levels and studies in mammalian and non-mammalian species show that E2 regulates proliferation (gonocytes, SPG, Leydig cells), apoptosis (pachytene SPC, Sertoli cells), and differentiation (SPTs) of germ and somatic cells, as well as it regulates spermiation, transport and motility of SPZ, epididymal sperm maturation, and scrotal testicular descent (42438097107116). Some of these functions are evolutionarily conserved from fish to mammals demonstrating that E2 plays an important role in male reproduction physiology in vertebrates (190117). Expression profiling of spermatogenesis in the rainbow trout identifies evolutionarily conserved genes involved in male gonadal maturation (118). Accordingly, E2-responsive genes have been characterized in gonads enriched of SPG or in isolated germ cells: in both frog (42108) and fish (118119), some of these genes are associated to proliferation.

To date, although tissue and cell culture experiments show that E2 may act on germ cells, its direct effect in in vivo systems has not yet been fully elucidated. However, data obtained in mouse, rat, and human models clearly show that E2 is important to produce and sustain high standard quality mature SPZ. Two main observations suggest that E2 is able to act locally into the testis: (1) germ cells express both P450arom and ER, in particular SPTs (120) produce E2 that may act via specific receptors (121); (2) Sertoli cell barrier envelops the germinal epithelium, from SPCs to SPTs/SPZ, ensuring a specific micro-environment that allows a correct germ cell progression.

In mouse, P450arom activity is high in germ cells and in particular in SPTs, while is lowered in the interstitial compartment (120). Among germ cells, mainly SPTs and SPZ are responsive to inhibition/inactivation of P450arom and to low E2 levels. Early studies, demonstrated that when rat (122123) or bonnet monkey (115) were treated with aromatase inhibitors, degeneration of round SPT and a massive decrease of elongated SPTs was found. Later, D’Souza showed that round SPT differentiation (steps 1–6) was largely dependent on E2, whereas SPT elongation (steps 8–19) was androgen dependent (124). Indeed, high intra-testicular E2 levels preserve round SPTs (steps 1–6) whereas T deficiency, induced by E2, originate pyknotic bodies in elongated/condensed SPTs (steps 8–19) (124). Consistently, loss of E2 in human testis promotes apoptosis of round SPTs with loss of elongated SPTs (125) and viable SPZ (126). Therefore, E2 is now considered as a survival factor for SPTs and SPZ.

The bulk of information about the role of E2 in germ cell differentiation, from SPT-to-SPZ, came from studies on mutant mice such as the hypogonadic (hpg), the Cyp19A1 knock-out (ArKO), and the Cb1knock-out (Cb1−/−) (55127128).

Due to a natural GnRH gene deletion, the hpg mice are functionally deficient in gonadotropins and sex steroids and show meiosis arrest at pachytene stage. Treatment with E2 or ERα agonists restored meiosis in these animals which, in absence of T, produce haploid elongated SPTs (129). The E2 treatment alone was as effective as FSH alone and the combination of both hormones did not produce a greater effect (130). Authors concluded that E2 likely acts on hpg testis via a mechanism involving a weak neuroendocrine activation of FSH secretion (128130).

The phenotype of ArKO mice and experimental analysis carried out using this mutant mice counteract with this conclusion. ArKO males (127) are initially fertile, but they develop progressive infertility between 4.5 months and 1 year. In the SPTs of these animals, multiple acrosome vesicles, irregularly scattered over the nuclear surface, are observed (127) suggesting that acrosome biogenesis may be an E2-dependent process. Accordingly, P450arom is at high levels in the Golgi complex of developing SPT (120). In ArKO mice, spermatogenesis is primarily arrested at early stages, with a decrease of round and elongated SPT numbers, without any detectable change of circulating FSH levels (127). Dietary phytoestrogens may partially prevent disruption of ArKO mice spermatogenesis, avoiding the decline of germ cell number. Interestingly, when young ArKO mice were exposed to a phytoestrogen free diet, the phenotype was severely disrupted as compared with mice under normal diet. This occurred in absence of a decreased gonadotropic stimulus, suggesting that the effects of dietary phytoestrogens are independent of changes concerning the pituitary–gonadal axis and they are probably related to direct activation of testicular ERs (131). In agreement with this conclusion, E2 administration in irradiated rats suppressed serum LH, FSH, and T (both plasma and intratesticular) levels (132) and produced the recovery of spermatogenesis (133134) suggesting a gonadotropin-independent E2 activity. However, gynecomastia and cardiovascular problems are secondary effects related to E2 treatment and represent the major impediment to clinical application. Recently, it has been suggested that the phytoestrogen genistein may be a true substitute for E2 (135).

Concerning the Cb1−/− mouse, it is a genetically modified animal model showing Cb1-gene deletion (136). This gene codifies CB1, which is broadly expressed in hypothalamus, pituitary, and testis (137138) of many vertebrates, from fish to mammals [for review see Ref. (52)]. CB1 is involved in GnRH and gonadotropin production (5557139141) at testicular level, it regulates both spermatogenesis (154658137138142145) and steroidogenesis (146147). Interestingly, Cb1−/− mice exhibit endocrine features in common with hpg and ArKO models: (1) down regulation of GnRH and GnRHR mRNA, (2) low LH release and low expression of FSHβ mRNA, (3) low T production, and (4) low E2 plasma levels. Morphological and molecular analyses of epididymis and 3β-HSD, which are responsive to T, suggest that even low, T levels are enough (55). Unlike hpg and ArKO mice, Cb1−/− mutants are fertile; they show a quantitatively normal production of SPZ although, similarly to some fertile men, a consistent aliquot shows abnormalities (148149) that are mainly related to the motility and to chromatin quality (histone content, chromatin packaging, DNA integrity, and nuclear size, useful parameters to classify sperm chromatin quality). Therefore, Cb1−/− mice exhibit endocrine and phenotypic features, which are useful to extend the above studies about the role of E2 in SPT differentiation and in the maintenance of sperm quality. Interestingly, when Cb1−/− mice were treated with E2, all the abovementioned chromatin quality indices improved in SPZ (55150). Therefore, sperm chromatin quality appears to be responsive to E2 treatment (151). Interestingly, ERα and ERβ polymorphisms have been associated with semen quality (152). Accordingly, P450arom, either mRNA or protein, has been proposed as marker of sperm quality in men. Indeed, Carreau and co-workers reported that, in human ejaculated SPZ, the immotile sperm fraction showed low levels of P450arom, both mRNA and protein activity (30 and 50%, respectively), as compared with the motile sperm fraction (153155). In addition, the same authors have recently reported that in SPZ from asthenospermic, teratospermic, and asthenoteratospermic patients, P450arom mRNA levels were progressively lower as compared with SPZ from control patients (156). The hypothesis that E2 treatment improves motility by enhancing oxidative metabolism and the intracellular ATP concentrations in human sperm (157158) well fit with the observation that E2 can regulate mitochondrial function in MCF7 cells by increasing nuclear respiratory factor-1 expression (159). However, in mouse, E2 and phytoestrogens are able to improve capacitation as well as acrosome reaction and fertilizing capacity of SPZ (160), while natural and synthetic estrogens have stimulatory effect on boar sperm capacitation in vitro (161).

Results from mutant animal models, here reported, in combination with case reports concerning patients with few testicular germ cells or decreased sperm motility and number, have a common root: they are characterized by E2 deficiency due to the mutation or low expression of Cyp19A1 gene ((126162164), suggesting that E2 may have a instrumental role in quality sperm and its action is much more complex than previously predicted or suggested by ERα knock-out mice, which show impaired fluid re-adsorption within the efferent ducts as cause of sterility (105).

Closing Remarks

In the last years, data provided by literature evidence that, besides endocrine route, intra-testicular paracrine and autocrine communications are fundamental to sustain spermatogenesis in order to gain high standard quality SPZ. New roles for stereotyped hypothalamic and female hormones – GnRH and E2, respectively emerged, new potential modulators such as kisspeptins have been identified as well, but conflicting data reveal that several issues need to be further investigated. The modulators here reported – GnRH, kisspeptin, and estrogens – are critical for a successful spermatogenesis as clearly demonstrated by clinical cases of infertility in humans. However, several questions are still open. These different modulators strongly cooperate at hypothalamic level whereas, at testicular level, they control similar events (Leydig cell functions, proliferation/differentiation events, sperm functions); conversely, their possible local crosstalk is far away to be elucidated. Similarly, they may trigger, independently from each other, pathways controlling the same aspects that might represent two sides of the same coin. Both a comparative approach and the use of genetically modified experimental models may represent a successful tool to make giant strides in the building of general models, but to extricate this intriguing story, there is still much to be done.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Acknowledgments

Every effort was made to include citation of the most salient findings in the field. We apologize to any author(s) whose work was not adequately cited. Financial support from the “Ministero Italiano dell’Istruzione, dell’Università e della Ricerca” PRIN 2010–2011 to Rosaria Meccariello, and PRIN 2010–2011 to Gilda Cobellis.

Author Contributions

Rosaria Meccariello, conception and design of the work, interpretation of data, manuscript drafting, critical revision, final approval of the submitted version; Rosanna Chianese, acquisition, analysis, interpretation of data for the work, manuscript drafting, final approval of the submitted version; Teresa Chioccarelli, acquisition, analysis, interpretation of data for the work, manuscript drafting, final approval of the submitted version; Vincenza Ciaramella, acquisition, analysis, interpretation of data for the work, manuscript drafting, final approval of the submitted version; Silvia Fasano, conception and design of the work, manuscript drafting, critical revision, final approval of the submitted version; Riccardo Pierantoni, conception and design of the work, manuscript drafting, critical revision, final approval of the submitted version; Gilda Cobellis, conception and design of the work, interpretation of data, manuscript drafting, critical revision, final approval of the submitted version.

References

1. Pierantoni R, Cobellis G, Meccariello R, Fasano S. Evolutionary aspects of cellular communication in the vertebrate hypothalamo-hypophysio-gonadal axisInt Rev Cytol (2002) 218:69–14110.1016/S0074-7696(02)18012-0  [PubMed] [Cross Ref]
2. Amoss M, Burgus R, Blackwell R, Vale W, Fellows R, Guillemin R. Purification, amino acid composition and N-terminus of the hypothalamic luteinizing hormone releasing factor (LRF) of ovine originBiochem Biophys Res Commun (1971) 44:205–1010.1016/S0006-291X(71)80179-1  [PubMed][Cross Ref]
3. Kah O, Lethimonier C, Somoza G, Guilgur LG, Vaillant C, Lareyre JJ. GnRH and GnRH receptors in metazoa: a historical, comparative, and evolutive perspectiveGen Comp Endocrinol (2007) 153:346–6410.1016/j.ygcen.2007.01.030  [PubMed] [Cross Ref]
4. Kavanaugh SI, Nozaki M, Sower SA. Origins of gonadotropin-releasing hormone (GnRH) in vertebrates: identification of a novel GnRH in a basal vertebrate, the sea lampreyEndocrinology (2008) 149:3860–910.1210/en.2008-0184 [PMC free article]  [PubMed] [Cross Ref]
5. Millar RP, Lu ZL, Pawson AJ, Flanagan CA, Morgan K, Maudsley SR. Gonadotropin-releasing hormone receptorsEndocr Rev (2004) 25:235–7510.1210/er.2003-0002  [PubMed] [Cross Ref]
6. Morgan K, Millar RP. Evolution of GnRH ligand precursors and GnRH receptors in protochordate and vertebrate speciesGen Comp Endocrinol (2004) 139:191–710.1016/j.ygcen.2004.09.015  [PubMed][Cross Ref]
7. Oh DY, Song JA, Moon JS, Moon MJ, Kim JI, Kim K, et al. Membrane-proximal region of the carboxyl terminus of the gonadotropin-releasing hormone receptor (GnRHR) confers differential signal transduction between mammalian and nonmammalian GnRHRsMol Endocrinol (2005) 19:722–3110.1210/me.2004-0220  [PubMed] [Cross Ref]
8. King JA, Millar RP. Evolutionary aspects of gonadotropin-releasing hormone and its receptorCell Mol Neurobiol (1995) 15:5–2310.1007/BF02069556  [PubMed] [Cross Ref]
9. Wu HM, Cheng JC, Wang HS, Huangm HY, MacCalman CD, Leung PC. Gonadotropin-releasing hormone type II induces apoptosis of human endometrial cancer cells by activating GADD45alphaCancer Res (2009) 69:4202–810.1158/0008-5472.CAN-08-4591  [PubMed] [Cross Ref]
10. Aguilar-Rojas A, Huerta-Reyes M. Human gonadotropin-releasing hormone receptor-activated cellular functions and signaling pathways in extra-pituitary tissues and cancer cellsOncol Rep (2009) 22:981–9010.3892/or_00000525  [PubMed] [Cross Ref]
11. Pawson AJ, Morgan K, Maudsley SR, Millar RP. Type II gonadotrophin-releasing hormone (GnRH-II) in reproductive biologyReproduction (2003) 126:271–810.1530/rep.0.1260271  [PubMed] [Cross Ref]
12. Sharpe RM. Paracrine control of the testisClin Endocrinol Metab (1986) 15:185–20710.1016/S0300-595X(86)80049-4  [PubMed] [Cross Ref]
13. Morales P, Pizzarro E, Kong M, Kerr B, Ceric F, Vigil P. Gonadotropin releasing hormone stimulated sperm binding to the human zona is mediated by a calcium influxBiol Reprod (2000) 63:635–4210.1095/biolreprod63.2.635  [PubMed] [Cross Ref]
14. Morales P, Pasten C, Pizzarro E. Inhibition of in vivo and in vivo fertilization in rodents by gonadotropin-releasing hormone antagonistBiol Reprod (2002) 67:1360–510.1095/biolreprod67.4.1360 [PubMed] [Cross Ref]
15. Pierantoni R, Cobellis G, Meccariello R, Cacciola G, Chianese R, Chioccarelli T, et al. Testicular gonadotropin-releasing hormone activity, progression of spermatogenesis, and sperm transport in vertebratesAnn N Y Acad Sci (2009) 1163:279–9110.1111/j.1749-6632.2008.03617.x  [PubMed][Cross Ref]
16. Chianese R, Chioccarelli T, Cacciola G, Ciaramella V, Fasano S, Pierantoni R, et al. The contribution of lower vertebrate animal models in human reproduction researchGen Comp Endocrinol (2011) 171:17–2710.1016/j.ygcen.2010.12.011  [PubMed] [Cross Ref]
17. Bahk JY, Hyun JS, Chung SH, Lee H, Kim MO, Lee BH, et al. Stage specific identification of the expression of GnRH mRNA and localization of the GnRH receptor in mature rat and adult human testisJ Urol (1995) 154:1958–6110.1097/00005392-199511000-00105  [PubMed] [Cross Ref]
18. White RB, Fernald RD. Genomic structure and expression sites of three gonadotropin-releasing hormone genes in one speciesGen Comp Endocrinol (1998) 112:217–2510.1006/gcen.1998.7125 [PubMed] [Cross Ref]
19. van Biljon W, Wykes S, Scherer S, Krawetz SA, Hapgood J. Type II gonadotropin-releasing hormone receptor transcripts in human spermBiol Reprod (2002) 67:1741–910.1095/biolreprod.101.002808 [PubMed] [Cross Ref]
20. Millar R, Conklin D, Lofton-Day C, Hutchinson E, Troskie B, Illing N, et al. A novel human GnRH receptor homolog gene: abundant and wide tissue distribution of the antisense transcriptJ Endocrinol(1999) 162:117–2610.1677/joe.0.1620117  [PubMed] [Cross Ref]
21. Pierantoni R, Fasano S, Di Matteo L, Minucci S, Varriale B, Chieffi G. Stimulatory effect of a GnRH agonist (buserelin) in in vitro and in vivo testosterone production by the frog (Rana esculenta) testisMol Cell Endocrinol (1984) 38:215–910.1016/0303-7207(84)90120-5  [PubMed] [Cross Ref]
22. Ramakrishnappa N, Rajamahendran R, Lin YM, Leung PC. GnRH in non-hypothalamic reproductive tissuesAnim Reprod Sci (2005) 88:95–11310.1016/j.anireprosci.2005.05.009  [PubMed] [Cross Ref]
23. Lin YM, Liu MY, Poon SL, Leu SF, Huang BM. Gonadotropin-releasing hormone-I and -II stimulate steroidogenesis in prepubertal murine Leydig cells in vitroAsian J Androl (2008) 10:929–3610.1111/j.1745-7262.2008.00434.x  [PubMed] [Cross Ref]
24. Fasano S, Pierantoni R, Minucci S, Di Matteo L, D’Antonio M, Chieffi G. Effects of intratesticular injections of estradiol and gonadotropin-releasing hormone (GnRHA, HOE 766) on plasma androgen levels in intact and hypophysectomized Torpedo marmorata and Torpedo ocellataGen Comp Endocrinol(1989) 75:349–5410.1016/0016-6480(89)90169-X  [PubMed] [Cross Ref]
25. King JA, Millar RP, Vallarino M, Pierantoni R. Localization and characterization of gonadotropin-releasing hormones in the brain, gonads, and plasma of a dipnoi (lungfish, Protopterus annectens)Regul Pept (1995) 57:163–7410.1016/0167-0115(95)00025-7  [PubMed] [Cross Ref]
26. Lin YM, Poon SL, Choi JH, Lin JS, Leung PC, Huang BM. Transcripts of testicular gonadotropin-releasing hormone, steroidogenic enzymes, and intratesticular testosterone levels in infertile menFertil Steril (2008) 90:1761–810.1016/j.fertnstert.2007.08.078  [PubMed] [Cross Ref]
27. Yao B, Liu HY, Gu YC, Shi SS, Tao XQ, Li XJ, et al. Gonadotropin-releasing hormone positively regulates steroidogenesis via extracellular signal-regulated kinase in rat Leydig cellsAsian J Androl(2011) 13:438–4510.1038/aja.2010.158 [PMC free article]  [PubMed] [Cross Ref]
28. Anjum S, Krishna A, Sridaran R, Tsutsui K. Localization of gonadotropin-releasing hormone (GnRH), gonadotropin-inhibitory hormone (GnIH), kisspeptin and GnRH receptor and their possible roles in testicular activities from birth to senescence in miceJ Exp Zool A Ecol Genet Physiol (2012) 317:630–4410.1002/jez.1765 [PMC free article]  [PubMed] [Cross Ref]
29. Ubuka T, Son YL, Tobari J, Narihiro M, Bentley GE, Kriegsfelf LJ, et al. Central and direct regulation of testicular activity by gonadotropin-inhibitory hormone and its receptorFront Endocrinol (2014) 5:8.10.3389/fendo.2014.00008 [PMC free article]  [PubMed] [Cross Ref]
30. Guo JJ, Ma X, Wang CQ, Ge YF, Lian QQ, Hardy DO, et al. Effect of luteinizing hormone and androgen on the development of rat progenitor Leydig cells in vitro and in vivoAsian J Androl (2013) 15:685–9110.1038/aja.2013.55 [PMC free article]  [PubMed] [Cross Ref]
31. So WK, Cheng JC, Poon SL, Leung PC. Gonadotropin-releasing hormone and ovarian cancer: a functional and mechanistic overviewFEBS J (2008) 275:5496–51110.1111/j.1742-4658.2008.06679.x [PubMed] [Cross Ref]
32. White CD, Stewart AJ, Lu ZL, Millar RP, Morgan K. Antiproliferative effects of GnRH agonists: prospects and problems for cancer therapyNeuroendocrinology (2008) 88:67–7910.1159/000119093 [PubMed] [Cross Ref]
33. Andreu-Vieyra CV, Buret AG, Habibi HR. Gonadotropin-releasing hormone induction of apoptosis in the testes of goldfish (Carassius auratus)Endocrinology (2005) 146:1588–9610.1210/en.2004-0818 [PubMed] [Cross Ref]
34. Soverchia L, Carotti M, Andreu-Vieyra C, Mosconi G, Cannella N, Habibi H, et al. Role of gonadotropin-releasing hormone (GnRH) in the regulation of gonadal differentiation in the gilthead seabream (Sparus aurata)Mol Reprod Dev (2007) 74:57–6710.1002/mrd.20484  [PubMed] [Cross Ref]
35. Ogawa T, Dobrinski I, Avarbock MR, Brinster RL. Leuprolide, a gonadotropin-releasing hormone agonist, enhances colonization after spermatogonial transplantation into mouse testesTissue Cell (1998) 30:583–810.1016/S0040-8166(98)80039-6  [PubMed] [Cross Ref]
36. Ogawa T, Dobrinski I, Brinster RL. Recipient preparation is critical for spermatogonial transplantation in the ratTissue Cell (1999) 31:461–7210.1054/tice.1999.0060  [PubMed] [Cross Ref]
37. Shuttlesworth GA, de Rooij DG, Huhtaniemi I, Reissmann T, Russel LD, Shetty G, et al. Enhancement of a spermatogonial proliferation and differentiation in irradiated rats by gonadotropin-releasing hormone antagonist administrationEndocrinology (2000) 141:37–4910.1210/en.141.1.37  [PubMed] [Cross Ref]
38. Treen N, Itoh N, Miura H, Kikuchi I, Ueda T, Takahashi KG, et al. Mollusc gonadotropin-releasing hormone directly regulates gonadal functions: a primitive endocrine system controlling reproductionGen Comp Endocrinol (2012) 176:167–7210.1016/j.ygcen.2012.01.008  [PubMed] [Cross Ref]
39. Minucci S, Di Matteo L, Pierantoni R, Varriale B, Rastogi RK, Chieffi G. In vivo and in vitrostimulatory effect of a gonadotropin-releasing hormone analog (HOE 766) on spermatogonial multiplication in the frog, Rana esculenta. Endocrinology (1986) 119:731–610.1210/endo-119-2-731 [PubMed] [Cross Ref]
40. Minucci S, Fasano S, Pierantoni R. Induction of S-phase entry by a gonadotropin releasing hormone agonist (buserelin) in the frog, Rana esculenta, primary spermatogoniaComp Biochem Physiol C Pharmacol Toxicol Endocrinol (1996) 113:99–10210.1016/0742-8413(95)02046-2  [PubMed] [Cross Ref]
41. Di Matteo L, Minucci S, Fasano S, Pierantoni R, Varriale B, Chieffi G. A gonadotropin-releasing hormone (GnRH) antagonist decreases androgen production and spermatogonial multiplication in frog (Rana esculenta): indirect evidence for the existence of GnRH or GnRH-like material receptors in the hypophysis and testisEndocrinology (1988) 122:62–710.1210/endo-122-1-62  [PubMed] [Cross Ref]
42. Cobellis G, Meccariello R, Fienga G, Pierantoni R, Fasano S. Cytoplasmic and nuclear Fos protein forms regulate resumption of spermatogenesis in the frog, Rana esculentaEndocrinology (2002) 143:163–7010.1210/en.143.1.163  [PubMed] [Cross Ref]
43. Cobellis G, Meccariello R, Minucci S, Palmiero C, Pierantoni R, Fasano S. Cytoplasmic versus nuclear localization of Fos-related proteins in the frog, Rana esculenta, testis: in vivo and direct in vitro effect of a gonadotropin-releasing hormone agonistBiol Reprod (2003) 68:954–6010.1095/biolreprod.102.008938 [PubMed] [Cross Ref]
44. Savulescu D, Feng J, Ping YS, Mai O, Boehm U, He B, et al. Gonadotropin-releasing hormone-regulated prohibitin mediates apoptosis of the gonadotrope cellsMol Endocrinol (2013) 27:1856–7010.1210/me.2013-1210  [PubMed] [Cross Ref]
45. Minucci S, Di Matteo L, Chieffi Baccari G, Pierantoni R. A gonadotropin releasing hormone analog induces spermiation in intact and hypophysectomized frogs, Rana esculentaExperientia (1989) 45:1118–2110.1007/BF01950175  [PubMed] [Cross Ref]
46. Chianese R, Ciaramella V, Scarpa D, Fasano S, Pierantoni R, Meccariello R. Anandamide regulates the expression of GnRH1GnRH2 and GnRHRs in frog testisAm J Physiol Endocrinol Metab (2012) 303:E475–8710.1152/ajpendo.00086.2012  [PubMed] [Cross Ref]
47. Zerani M, Catone G, Quassinti L, Maccari E, Bramucci M, Gobbetti A, et al. In vitro effects of gonadotropin-releasing hormone (GnRH) on Leydig cells of adult alpaca (Lama pacos) testis: GnRH receptor immunolocalization, testosterone and prostaglandin synthesis, and cyclooxygenase activitiesDomest Anim Endocrinol (2011) 40:51–910.1016/j.domaniend.2010.08.006  [PubMed] [Cross Ref]
48. Chianese R, Ciaramella V, Fasano S, Pierantoni R, Meccariello R. Anandamide modulates the expression of GnRH-II and GnRHRs in frog, Rana esculenta, diencephalonGen Comp Endocrinol (2011) 173:389–9510.1016/j.ygcen.2011.07.001  [PubMed] [Cross Ref]
49. Cacciola G, Chianese R, Chioccarelli T, Ciaramella V, Fasano S, Pierantoni R, et al. Cannabinoid and reproduction: a lasting and intriguing historyPharmaceuticals (2010) 3:3275–32310.3390/ph3103275 [Cross Ref]
50. Pierantoni R, Cobellis G, Meccariello R, Cacciola G, Chianese R, Chioccarelli T, et al. CB1 activity in male reproduction: mammalian and nonmammalian anima modelsVitam Horm (2009) 81:367–8710.1016/S0083-6729(09)81014-5  [PubMed] [Cross Ref]
51. Battista N, Meccariello R, Cobellis G, Fasano S, Di Tommaso M, Pirazzi V, et al. The role of endocannabinoids in gonadal function and fertility along the evolutionary axisMol Cell Endocrinol (2012) 355:1–1410.1016/j.mce.2012.01.014  [PubMed] [Cross Ref]
52. Meccariello R, Battista N, Bradshaw HB, Wang H. Updates in reproduction coming from the endocannabinoid systemInt J Endocrinol (2014) 2014(412354):16.10.1155/2014/412354 [PMC free article]  [PubMed] [Cross Ref]
53. Scorticati C, Fernandez-Solari J, De Laurentiis A, Mohn C, Prestifilippo JP, Lasaga M, et al. The inhibitory effect of anandamide on luteinizing hormone-releasing hormone secretion is reversed by oestrogenProc Natl Acad Sci U S A (2004) 32:11891–610.1073/pnas.0404366101 [PMC free article][PubMed] [Cross Ref]
54. Farkas I, Kallo I, Deli L, Vida B, Hrabovszky E, Fekete C, et al. Retrograde endocannabinoids signaling reduces GABAergic synaptic transmission to gonadotropin-releasing hormone neuronsEndocrinology (2010) 151:5818–2910.1210/en.2010-0638 [PMC free article]  [PubMed] [Cross Ref]
55. Cacciola G, Chioccarelli T, Altucci L, Ledent C, Mason JI, Fasano S, et al. Low 17beta-estradiol levels in CNR1 knock-out mice affect spermatid chromatin remodeling by interfering with chromatin reorganizationBiol Reprod (2013) 152:1–1210.1095/biolreprod.112.105726  [PubMed] [Cross Ref]
56. Meccariello R, Franzoni MF, Chianese R, Cottone E, Scarpa D, Donna D, et al. Interplay between the endocannabinoid system and GnRH-I in the forebrain oh the anuran amphibian Rana esculentaEndocrinology (2008) 149:2149–5810.1210/en.2007-1357  [PubMed] [Cross Ref]
57. Chianese R, Cobellis G, Pierantoni R, Fasano S, Meccariello R. Non-mammalian vertebrate models and the endocannabinoid system: relationships with gonadotropin-releasing hormoneMol Cell Endocrinol(2008) 286:S46–5110.1016/j.mce.2008.01.009  [PubMed] [Cross Ref]
58. Chianese R, Ciaramella V, Scarpa D, Fasano S, Pierantoni R, Meccariello R. Endocannabinoids and endovanilloids: a possible balance in the regulation of testicular GnRH signalingInt J Endocrinol (2013) 2013:904748.10.1155/2013/904748 [PMC free article]  [PubMed] [Cross Ref]
59. Lee JH, Miele ME, Hicks DJ, Phillips KK, Trent JM, Weissman BE, et al. Kiss-1, a novel human malignant melanoma metastasis-suppressor geneJ Natl Cancer Inst (1996) 88:1731–710.1093/jnci/88.23.1731  [PubMed] [Cross Ref]
60. Kotani M, Detheux M, Vandenbogaerde A, Communi D, Vanderwinden JM, Le Poul E, et al. The metastasis suppressor gene Kiss-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54J Biol Chem (2001) 276:34631–610.1074/jbc.M104847200  [PubMed] [Cross Ref]
61. Messager S, Chatzidaki EE, Ma D, Hendrick AG, Zahn D, Dixon J, et al. Kisspeptin directly stimulates gonadotropin releasing hormone release via G protein coupled receptor 54Proc Natl Acad Sci U S A(2005) 102:1761–610.1073/pnas.0409330102 [PMC free article]  [PubMed] [Cross Ref]
62. Seminara SB, Messager S, Chatzidaki EE, Thresher RR, Acierno JS, Shagoury JK, et al. The GPR54 gene as a regulator of pubertyN Engl J Med (2003) 349:1614–2710.1056/NEJMoa035322  [PubMed][Cross Ref]
63. de Roux N, Genin E, Carel JC, Matsuda F, Chaussain JL, Milgrom E. Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54Proc Natl Acad Sci U S A (2003) 100:10972–610.1073/pnas.1834399100 [PMC free article]  [PubMed] [Cross Ref]
64. Beck BH, Fuller SA, Peatman E, McEntire ME, Darwish A, Freeman DW. Chronic exogenous kisspeptin administration accelerates gonadal development in basses of the genus MoroneComp Biochem Physiol A Mol Integr Physiol (2012) 162:265–7310.1016/j.cbpa.2012.03.019  [PubMed] [Cross Ref]
65. Nocillado JN, Zohar Y, Biran J, Levavi-Sivan B, Elizur A. Chronic kisspeptin administration stimulated gonadal development in pre-pubertal male yellowtail kingfish (Seriola lalandi; perciformes) during the breeding and non-breeding seasonGen Comp Endocrinol (2013) 191:168–7610.1016/j.ygcen.2013.06.005  [PubMed] [Cross Ref]
66. Selvaraj S, Ohga H, Nyuji M, Kitano H, Nagano N, Yamaguchi A, et al. Subcutaneous administration of Kiss1 pentadecapeptide accelerates spermatogenesis in prepubertal male chub mackerel (Scomber japonicus)Comp Biochem Physiol A Mol Integr Physiol (2013) 166:228–3610.1016/j.cbpa.2013.06.007 [PubMed] [Cross Ref]
67. Selvaraj S, Ohga H, Kitano H, Nyuji M, Yamaguchi A, Matsuyama M. Peripheral administration of Kiss1 pentadecapeptide induces gonadal development in sexually immature adult scombroid fishZoolog Sci (2013) 30:446–5410.2108/zsj.30.446  [PubMed] [Cross Ref]
68. Saito H, Sawada T, Yaegashi T, Goto Y, Jin J, Sawai K, et al. Kisspeptin-10 stimulates the release of luteinizing hormone and testosterone in pre- and post-pubertal male goatsAnim Sci J (2012) 83:487–9210.1111/j.1740-0929.2011.00978.x  [PubMed] [Cross Ref]
69. Kauffman AS. Coming of age in the kisspeptin era: sex differences, development, and pubertyMol Cell Endocrinol (2010) 324:51–6310.1016/j.mce.2010.01.017 [PMC free article]  [PubMed] [Cross Ref]
70. Demirbilek H, Gonc EN, Ozon A, Alikasifoglu A, Kandemir N. Evaluation of serum kisspeptin levels in girls in the diagnosis of central precocious puberty and in the assessment of pubertal suppressionJ Pediatr Endocrinol Metab (2012) 25:313–610.1515/jpem-2011-0445  [PubMed] [Cross Ref]
71. Ratnasabapathy R, Dhillo WS. The effects of kisspeptin in human reproductive function therapeutic implicationsCurr Drug Targets (2013) 14:365–7110.2174/138945013804998981  [PubMed] [Cross Ref]
72. Oakley AE, Clifton DK, Steiner RA. Kisspeptin signaling in the brainEndocr Rev (2009) 30:713–4310.1210/er.2009-0005 [PMC free article]  [PubMed] [Cross Ref]
73. Mayer C, Boehm U. Female reproductive maturation in the absence of kisspeptin/GPR54 signalingNat Neurosci (2011) 14:704–1010.1038/nn.2818  [PubMed] [Cross Ref]
74. Popa SM, Moriyama RM, Caligioni CS, Yang JJ, Cho CM, Concepcion TL, et al. Redundancy in Kiss1 expression safeguards reproduction in the mouseEndocrinology (2013) 154:2784–9410.1210/en.2013-1222 [PMC free article]  [PubMed] [Cross Ref]
75. Ohtaki T, Shintani Y, Honda S, Matsumoto H, Hori A, Kanehashi K, et al. Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptorNature (2001) 411:613–710.1038/35079135  [PubMed] [Cross Ref]
76. Funes S, Hedrick JA, Vassileva G, Markowitz L, Abbondanzo S, Golovko A, et al. The KiSS-1 receptor GPR54 is essential for the development of the murine reproductive systemBiochem Biophys Res Commun (2003) 312:1357–6310.1016/j.bbrc.2003.11.066  [PubMed] [Cross Ref]
77. Terao Y, Kumano S, Takatsu Y, Hattori M, Nishimura A, Ohtaki T, et al. Expression of KiSS-1, a metastasis suppressor gene, in trophoblast giant cells of the rat placentaBiochim Biophys Acta (2004) 1678:102–1010.1016/j.bbaexp.2004.02.005  [PubMed] [Cross Ref]
78. Tariq AR, Shahab M, Clarke IJ, Pereira A, Smith JT, Khan SH, et al. Kiss1 and kiss1 receptor expression in the rhesus monkey testis: a possible local regulator of testicular functionCent Eur J Biol(2013) 8:968–7410.2478/s11535-013-0219-4 [Cross Ref]
79. Irfan S, Ehmcke J, Wahab F, Shahab M, Schlatt S. Intratesticular action of kisspeptin in rhesus monkey (Macaca mulatta)Andrologia (2013).10.1111/and.12121  [PubMed] [Cross Ref]
80. Chianese R, Ciaramella V, Fasano S, Pierantoni R, Meccariello R. Kisspeptin receptor, GPR54, as a candidate for the regulation of testicular activity in the frog Rana esculentaBiol Reprod (2013) 88:73.10.1095/biolreprod.112.103515  [PubMed] [Cross Ref]
81. Ramzan F, Qureshi IZ. Intraperitoneal kisspeptin-10 administration induces dose-dependent degenerative changes in maturing rat testesLife Sci (2011) 88:246–5610.1016/j.lfs.2010.11.019  [PubMed][Cross Ref]
82. Thompson EL, Murphy KG, Patterson M, Bewick GA, Stamp GW, Curtis AE, et al. Chronic subcutaneous administration of kisspeptin-54 causes testicular degeneration in adult male ratsAm J Physiol Endocrinol Metab (2006) 291:E1074–8210.1152/ajpendo.00040.2006  [PubMed] [Cross Ref]
83. Ramzan F, Qureshi IZ, Ramzan M, Ramzan MH, Ramzan F. Immature rat seminal vesicles show histomorphological and ultrastructural alterations following treatment with kisspeptin-10Reprod Biol Endocrinol (2012) 10:18.10.1186/1477-7827-10-18 [PMC free article]  [PubMed] [Cross Ref]
84. Ramzan F, Qureshi IZ, Ramzan M, Ramzan MH, Ramzan F. Kisspeptin-10 induces dose dependent degeneration in prepubertal rat prostate glandProstate (2013) 73:690–910.1002/pros.22609  [PubMed][Cross Ref]
85. Mei H, Doran J, Kyle V, Yeo SH, Colledge WH. Does kisspeptin signalling have a role in the testes?Front Endocrinol (2013) 4:198.10.3389/fendo.2013.00198 [PMC free article]  [PubMed] [Cross Ref]
86. Shahab M, Mastronardi C, Seminara SB, Crowley WF, Ojeda SR, Plant TM. Increased hypothalamic GPR54 signaling: a potential mechanism for initiation of puberty in primatesProc Natl Acad Sci U S A(2005) 102:2129–3410.1073/pnas.0409822102 [PMC free article]  [PubMed] [Cross Ref]
87. Roseweir AK, Kauffman AS, Smith JT, Guerriero KA, Morgan K, Pielecka-Fortuna J, et al. Discovery of potent kisspeptin antagonists delineate physiological mechanisms of gonadotropin regulationJ Neurosci(2009) 29:3920–910.1523/JNEUROSCI.5740-08.2009 [PMC free article]  [PubMed] [Cross Ref]
88. Pinto FM, Cejudo-Román A, Ravina CG, Fernández-Sánchez M, Martín-Lozano D, Illanes M, et al. Characterization of the kisspeptin system in human spermatozoaInt J Androl (2012) 35:63–7310.1111/j.1365-2605.2011.01177.x  [PubMed] [Cross Ref]
89. Hsu MC, Wang JY, Lee YJ, Jong DS, Tsui KH, Chiu CH. Kisspeptin modulates fertilization capability of mouse spermatozoaReproduction (2014).10.1530/REP-13-0368  [PubMed] [Cross Ref]
90. Pierantoni R, Cobellis G, Meccariello R, Palmiero C, Fienga G, Minucci S, et al. The amphibian testis as model to study germ cell progression during spermatogenesisBiochem Physiol B Biochem Mol Biol(2002) 132:131–910.1016/S1096-4959(01)00543-7  [PubMed] [Cross Ref]
91. Rastogi RK, Iela L, Saxena PK, Chieffi G. The control of spermatogenesis in the green frog, Rana esculentaJ Exp Zool (1976) 169:151–6610.1002/jez.1401960203 [Cross Ref]
92. Fasano S, Minucci S, Di Matteo L, D’Antonio M, Pierantoni R. Intratesticular feedback mechanisms in the regulation of steroid profiles in the frog, Rana esculentaGen Comp Endocrinol (1989) 75:335–4210.1016/0016-6480(89)90167-6  [PubMed] [Cross Ref]
93. Sirianni R, Chimento A, Ruggiero C, De Luca A, Lappano R, Andò S, et al. The novel estrogen receptor, G protein-coupled receptor 30, mediates the proliferative effects induced by 17beta-estradiol on mouse spermatogonial GC-1 cell lineEndocrinology (2008) 149:5043–5110.1210/en.2007-1593 [PubMed] [Cross Ref]
94. Chimento A, Sirianni R, Casaburi I, Pezzi V. Role of estrogen receptors (ERs) and G protein-coupled estrogen receptor (GPER) in regulation of hypothalamic-pituitary-testis axis and spermatogenesisFront Endocrinol (2014) 5:1.10.3389/fendo.2014.00001 [PMC free article]  [PubMed] [Cross Ref]
95. Lidke AK, Bannister S, Löwer AM, Apel DM, Podleschny M, Kollmann M, et al. 17β-Estradiol induces supernumerary primordial germ cells in embryos of the polychaete Platynereis dumeriliiGen Comp Endocrinol (2014) 196:52–6110.1016/j.ygcen.2013.11.017  [PubMed] [Cross Ref]
96. Huma T, Ullah F, Hanif F, Rizak JD, Shahab M. Peripheral administration of kisspeptin antagonist does not alter basal plasma testosterone but decreases plasma adiponectin levels in adult male rhesus macaquesEur J Sci Res (2013) 109:668–7710.3906/biy-1401-53 [Cross Ref]
97. Carreau S, Bouraima-Lelong H, Delalande C. Estrogens in male germ cellsSpermatogenesis (2011) 1:90–410.4161/spmg.1.2.16766 [PMC free article]  [PubMed] [Cross Ref]
98. Maggiolini M, Picard D. The unfolding stories of GPR30, a new membrane-bound estrogen receptorJ Endocrinol (2010) 204:105–1410.1677/JOE-09-0242  [PubMed] [Cross Ref]
99. Liu X, Zhu P, Sham KW, Yuen JM, Xie C, Zhang Y, et al. Identification of a membrane estrogen receptor in zebrafish with homology to mammalian GPR30 and its high expression in early germ cells of the testisBiol Reprod (2009) 80:1253–6110.1095/biolreprod.108.070250  [PubMed] [Cross Ref]
100. Chimento A, Sirianni R, Delalande C, Silandre D, Bois C, Andò S, et al. 17 Beta-estradiol activates rapid signaling pathways involved in rat pachytene spermatocytes apoptosis through GPR30 and ER alphaMol Cell Endocrinol (2010) 320:136–4410.1016/j.mce.2010.01.035  [PubMed] [Cross Ref]
101. Alves MG, Socorro S, Silva J, Barros A, Sousa M, Cavaco JE, et al. In vitro cultured human Sertoli cells secrete high amounts of acetate that is stimulated by 17β-estradiol and suppressed by insulin deprivationBiochim Biophys Acta (2012) 1823:1389–9410.1016/j.bbamcr.2012.06.002  [PubMed][Cross Ref]
102. Rago V, Romeo F, Giordano F, Maggiolini M, Carpino A. Identification of the estrogen receptor GPER in neoplastic and non-neoplastic human testesReprod Biol Endocrinol (2011) 9:135.10.1186/1477-7827-9-135 [PMC free article]  [PubMed] [Cross Ref]
103. O’Donnell L, Robertson KM, Jones ME, Simpson ER. Estrogen and spermatogenesisEndocr Rev(2001) 22:289–31810.1210/er.22.3.289  [PubMed] [Cross Ref]
104. Shanbacker BD. Regulation of luteinizing hormone secretion in male sheep by endogenous estrogenEndocrinology (1974) 115:944–5010.1210/endo-115-3-944  [PubMed] [Cross Ref]
105. Eddy EM, Washburn TF, Bunch DO, Goulding EH, Gladen BC, Lubahn DB, et al. Targeted disruption of the estrogen receptor gene in male mice causes alteration of spermatogenesis and infertilityEndocrinology (1996) 137:4796–80510.1210/en.137.11.4796  [PubMed] [Cross Ref]
106. Hess RA, Bunick D, Lee KH, Bahr J, Taylor JA, Korach KS, et al. A role for oestrogens in the male reproductive systemNature (1997) 390:509–1210.1038/37352  [PubMed] [Cross Ref]
107. Miura T, Miura C, Ohta T, Nader MR, Todo T, Yamauchi K. Estradiol-17β stimulates the renewal of spermatogonial stem cells in malesBiochem Biophys Res Commun (1999) 264:230–410.1006/bbrc.1999.1494  [PubMed] [Cross Ref]
108. Cobellis G, Pierantoni R, Minucci S, Pernas-Alonso R, Meccariello R, Fasano S. c-Fos activity in Rana esculenta testis: seasonal and estradiol-induced changesEndocrinology (1999) 140:3238–4410.1210/en.140.7.3238  [PubMed] [Cross Ref]
109. Cobellis G, Lombardi M, Scarpa D, Izzo G, Fienga G, Meccariello R, et al. Fra-1 activity in the frog, Rana esculenta, testisAnn N Y Acad Sci (2005) 1040:264–810.1196/annals.1327.039  [PubMed][Cross Ref]
110. Cobellis G, Lombardi M, Scarpa D, Izzo G, Fienga G, Meccariello R, et al. Fra1 activity in the frog, Rana esculenta, testis: a new potential role in sperm transportBiol Reprod (2005) 72:1101–810.1095/biolreprod.104.036541  [PubMed] [Cross Ref]
111. Cobellis G, Cacciola G, Chioccarelli T, Izzo G, Meccariello R, Pierantoni R, et al. Estrogen regulation of the male reproductive tract in the frog, Rana esculenta: a role in Fra-1 activation in peritubular myoid cells and in sperm releaseGen Comp Endocrinol (2008) 155:838–4610.1016/j.ygcen.2007.10.004 [PubMed] [Cross Ref]
112. Lucas TF, Pimenta MT, Pisolato R, Lazari MF, Porto CS. 17Beta-estradiol signaling and regulation of Sertoli cell functionSpermatogenesis (2011) 1:318–2410.4161/spmg.1.4.18903 [PMC free article][PubMed] [Cross Ref]
113. Ruwanpura SM, McLachlan RI, Meachem SJ. Hormonal regulation of male germ cell developmentJ Endocrinol (2010) 205:117–3110.1677/JOE-10-0025  [PubMed] [Cross Ref]
114. Shetty G, Krishnamurthy H, Krishnamurthy HN, Bhatnagar S, Moudgal RN. Effect of estrogen deprivation on the reproductive physiology of male and female primatesJ Steroid Biochem Mol Biol(1997) 61:157–6610.1016/S0960-0760(97)80008-8  [PubMed] [Cross Ref]
115. Shetty G, Krishnamurthy H, Krishnamurthy HN, Bhatnagar AS, Moudgal NR. Effect of long-term treatment with aromatase inhibitor on testicular function of adult male bonnet monkeys (M. radiata)Steroids (1998) 63:414–2010.1016/S0039-128X(98)00042-7  [PubMed] [Cross Ref]
116. Staub C, Rauch M, Ferrière F, Trépos M, Dorval-Coiffec I, Saunders PT, et al. Expression of estrogen receptor ESR1 and its 46-kDa variant in the gubernaculum testisBiol Reprod (2005) 73:703–1210.1095/biolreprod.105.042796  [PubMed] [Cross Ref]
117. Schulz RW, de França LR, Lareyre JJ, Le Gac F, Chiarini-Garcia H, Nobrega RH, et al. Spermatogenesis in fishGen Comp Endocrinol (2010) 165:390–41110.1016/j.ygcen.2009.02.013 [PubMed] [Cross Ref]
118. Rolland AD, Lareyre JJ, Goupil AS, Montfort J, Ricordel MJ, Esquerré D, et al. Expression profiling of rainbow trout testis development identifies evolutionary conserved genes involved in spermatogenesisBMC Genomics (2009) 10:546.10.1186/1471-2164-10-546 [PMC free article]  [PubMed] [Cross Ref]
119. Pinto PI, Teodósio HR, Galay-Burgos M, Power DM, Sweeney GE, Canário AV. Identification of estrogen-responsive genes in the testis of sea bream (Sparus auratus) using suppression subtractive hybridizationMol Reprod Dev (2006) 73:318–2910.1002/mrd.20402  [PubMed] [Cross Ref]
120. Nitta H, Bunick D, Hess RA, Janulis L, Newton SC, Milette CF, et al. Germ cells of the mouse testis express P450 aromataseEndocrinology (1993) 132:1396–40110.1210/en.132.3.1396  [PubMed][Cross Ref]
121. Carreau S, Bouraima-Lelong H, Delalande C. Role of estrogens in spermatogenesisFront Biosci (Elite Ed) (2012) 4:1–1110.2741/356  [PubMed] [Cross Ref]
122. Tsutsumi I, Toppari J, Campeau JD, Di Zerega GS. Reduction of fertility in the male rat by systemic treatment with follicle regulatory proteinFertil Steril (1987) 47:689–95  [PubMed]
123. Tsutsumi I, Fugimori K, Nakamura RM. Disruption of seminiferous epithelial function in the rat by ovarian proteinBiol Reprod (1987) 36:451–6110.1095/biolreprod36.2.451  [PubMed] [Cross Ref]
124. D’Souza R, Gill-Sharma MK, Pathak S, Kedia N, Kumar R, Balasinor N. Effect of high intratesticular estrogen on the seminiferous epithelium in adult male ratsMol Cell Endocrinol (2005) 241:41–810.1016/j.mce.2005.04.011  [PubMed] [Cross Ref]
125. Pentikäinen V, Erkkilä K, Suomalainen L, Parvinen M, Dunkel L. Estradiol acts as a germ cell survival factor in the human testis in vitroJ Clin Endocrinol Metab (2000) 85:2057–6710.1210/jcem.85.5.6600  [PubMed] [Cross Ref]
126. Lanfranco F, Zirilli L, Baldi M, Pignatti E, Corneli G, Ghigo E, et al. A novel mutation in the human aromatase gene: insights on the relationship among serum estradiol, longitudinal growth and bone mineral density in an adult man under estrogen replacement treatmentBone (2008) 43:628–3510.1016/j.bone.2008.05.011  [PubMed] [Cross Ref]
127. Robertson KM, O’Donnell L, Jones ME, Meachem SJ, Boon WC, Fisher CR, et al. Impairment of spermatogenesis in mice lacking a functional aromatase (cyp 19) geneProc Natl Acad Sci U S A (1999) 96:7986–9110.1073/pnas.96.14.7986 [PMC free article]  [PubMed] [Cross Ref]
128. Ebling FJ, Brooks AN, Cronin AS, Ford H, Kerr JB. Estrogenic induction of spermatogenesis in the hypogonadal mouseEndocrinology (2000) 141:2861–910.1210/en.141.8.2861  [PubMed] [Cross Ref]
129. Allan CM, Couse JF, Simanainen U, Spaliviero J, Jimenez M, Rodriguez K, et al. Estradiol induction of spermatogenesis is mediated via an estrogen receptor-falphag mechanism involving neuroendocrine activation of follicle-stimulating hormone secretionEndocrinology (2010) 151:2800–1010.1210/en.2009-1477 [PMC free article]  [PubMed] [Cross Ref]
130. Baines H, Nwagwu MO, Hastie GR, Wiles RA, Mayhew TM, Ebling FJ. Effects of estradiol and FSH on maturation of the testis in the hypogonadal (hpg) mouseReprod Biol Endocrinol (2008) 6:4.10.1186/1477-7827-6-4 [PMC free article]  [PubMed] [Cross Ref]
131. Robertson KM, O’Donnell L, Simpson ER, Jones ME. The phenotype of the aromatase knockout mouse reveals dietary phytoestrogens impact significantly on testis functionEndocrinology (2002) 143:2913–2110.1210/en.143.8.2913  [PubMed] [Cross Ref]
132. Shetty G, Weng CC, Bolden-Tiller OU, Huhtaniemi I, Handelsman DJ, Meistrich ML. Effects of medroxyprogesterone and estradiol on the recovery of spermatogenesis in irradiated ratsEndocrinology(2004) 145:4461–910.1210/en.2004-0440  [PubMed] [Cross Ref]
133. Zhou W, Bolden-Tiller OU, Shao SH, Weng CC, Shetty G, AbuElhija M, et al. Estrogen-regulated genes in rat testes and their relationship to recovery of spermatogenesis after irradiationBiol Reprod(2011) 85:823–3310.1095/biolreprod.111.091611 [PMC free article]  [PubMed] [Cross Ref]
134. Porter KL, Shetty G, Shuttlesworth GA, Weng CC, Huhtaniemi I, Pakarinen P, et al. Estrogen enhances recovery from radiation-induced spermatogonial arrest in rat testesJ Androl (2009) 30:440–5110.2164/jandrol.108.006635  [PubMed] [Cross Ref]
135. Chi H, Chun K, Son H, Kim J, Kim G, Roh S. Effect of genistein administration on the recovery of spermatogenesis in the busulfan-treated rat testisClin Exp Reprod Med (2013) 40:60–610.5653/cerm.2013.40.2.60 [PMC free article]  [PubMed] [Cross Ref]
136. Ledent C, Valverde O, Cossu G, Petitet F, Aubert JF, Beslot F, et al. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout miceScience (1999) 283:401–410.1126/science.283.5400.401  [PubMed] [Cross Ref]
137. Cobellis G, Cacciola G, Scarpa D, Meccariello R, Chianese R, Franzoni MF, et al. Endocannabinoid system in frog and rodent testis: type-1 cannabinoid receptor and fatty acid amide hydrolase activity in male germ cellsBiol Reprod (2006) 75:82–910.1095/biolreprod.106.051730  [PubMed] [Cross Ref]
138. Cacciola G, Chioccarelli T, Ricci G, Meccariello R, Fasano S, Pierantoni R, et al. The endocannabinoid system in vertebrate male reproduction: a comparative overviewMol Cell Endocrinol(2008) 286:S24–3010.1016/j.mce.2008.01.004  [PubMed] [Cross Ref]
139. Wenger T, Ledent C, Tramu G. The endogenous cannabinoid, anandamide, activates the hypothalamo-pituitary-adrenal axis in CB1 cannabinoid receptor knockout miceNeuroendocrinology (2003) 78:294–30010.1159/000074882  [PubMed] [Cross Ref]
140. Maccarrone M, Wenger T. Effects of cannabinoids on hypothalamic and reproductive functionHandb Exp Pharmacol (2005) 168:555–7110.1007/3-540-26573-2_18  [PubMed] [Cross Ref]
141. Oláh M, Milloh H, Wenger T. The role of endocannabinoids in the regulation of luteinizing hormone and prolactin release. Differences between the effects of AEA and 2AGMol Cell Endocrinol (2008) 286:S36–4010.1016/j.mce.2008.01.005  [PubMed] [Cross Ref]
142. Grimaldi P, Orlando P, Di Siena S, Lolicato F, Petrosino S, Bisogno T, et al. The endocannabinoid system and pivotal role of the CB2 receptor in mouse spermatogenesisProc Natl Acad Sci U S A (2009) 106:11131–610.1073/pnas.0812789106 [PMC free article]  [PubMed] [Cross Ref]
143. Fasano S, Meccariello R, Cobellis G, Chianese R, Cacciola G, Chioccarelli T, et al. The endocannabinoid system: an ancient signaling involved in the control of male fertilityAnn N Y Acad Sci(2009) 1163:112–2410.1111/j.1749-6632.2009.04437.x  [PubMed] [Cross Ref]
144. Cacciola G, Chioccarelli T, Mackie K, Meccariello R, Ledent C, Fasano S, et al. Expression of type-1 cannabinoid receptor during rat postnatal testicular development: possible involvement in adult Leydig cell differentiationBiol Reprod (2008) 79:758–6510.1095/biolreprod.108.070128  [PubMed] [Cross Ref]
145. Meccariello R, Chianese R, Cacciola G, Cobellis G, Pierantoni R, Fasano S. Type-1 cannabinoid receptor expression in the frog, Rana esculenta, tissues: a possible involvement in the regulation of testicular activityMol Reprod Dev (2006) 73:551–810.1002/mrd.20434  [PubMed] [Cross Ref]
146. Wenger T, Ledent C, Csernus V, Gerendai I. The central cannabinoid receptor inactivation suppresses endocrine reproductive functionsBiochem Biophys Res Commun (2001) 284:363–810.1006/bbrc.2001.4977  [PubMed] [Cross Ref]
147. Chianese R, Ciaramella V, Fasano S, Pierantoni R, Meccariello R. Hypothalamus-pituitary axis: an obligatory target for endocannabinoids to inhibit steroidogenesis in frog testisGen Comp Endocrinol(2014).10.1016/j.ygcen.2014.02.010  [PubMed] [Cross Ref]
148. Cobellis G, Ricci G, Cacciola G, Orlando P, Petrosino S, Cascio MG, et al. A gradient of 2-arachidonoylglycerol regulates mouse epididymal sperm cell start-upBiol Reprod (2010) 82:451–810.1095/biolreprod.109.079210  [PubMed] [Cross Ref]
149. Ricci G, Cacciola G, Altucci L, Meccariello R, Pierantoni R, Fasano S, et al. Endocannabinoid control of sperm motility: the role of epididymisGen Comp Endocrinol (2007) 153:320–210.1016/j.ygcen.2007.02.003  [PubMed] [Cross Ref]
150. Cacciola G, Chioccarelli T, Altucci L, Viaggiano A, Fasano S, Pierantoni R, et al. Nuclear size as estrogen-responsive chromatin quality parameter of mouse spermatozoaGen Comp Endocrinol (2013) 193:201–910.1016/j.ygcen.2013.07.018  [PubMed] [Cross Ref]
151. Cacciola G, Chioccarelli T, Fasano S, Pierantoni R, Cobellis G. Estrogens and spermiogenesis: new insights from type 1 cannabinoid receptor knockout miceInt J Endocrinol (2013) 2013:501350.10.1155/2013/501350 [PMC free article]  [PubMed] [Cross Ref]
152. Lazaros LA, Xita NV, Kaponis AI, Zikopoulos KA, Plachouras NI, Georgiou IA. Estrogen receptor alpha and beta polymorphisms are associated with semen qualityJ Androl (2010) 31:291–810.2164/jandrol.109.007542  [PubMed] [Cross Ref]
153. Lambard S, Galeraud-Denis I, Bouraïma H, Bourguiba S, Chocat A, Carreau S. Expression of aromatase in human ejaculated spermatozoa: a putative marker of motilityMol Hum Reprod (2003) 9:117–2410.1093/molehr/gag020  [PubMed] [Cross Ref]
154. Lambard S, Galeraud-Denis I, Martin G, Levy R, Chocat A, Carreau S. Analysis and significance of mRNA in human ejaculated sperm from normozoospermic donors: relationship to sperm motility and capacitationMol Hum Reprod (2004) 10:535–4110.1093/molehr/gah064  [PubMed] [Cross Ref]
155. Lambard S, Galeraud-Denis I, Saunders PT, Carreau S. Human immature germ cells and ejaculated spermatozoa contain aromatase and oestrogen receptorsJ Mol Endocrinol (2004) 32:279–8910.1677/jme.0.0320279  [PubMed] [Cross Ref]
156. Said L, Saad A, Carreau S. Differential expression of mRNA aromatase in ejaculated spermatozoa from infertile men in relation to either asthenozoospermia or teratozoospermiaAndrologia (2014) 46:136–4610.1111/and.12058  [PubMed] [Cross Ref]
157. Beck KJ, Herschel S, Hungershöfer R, Schwinger E. The effect of steroid hormones on motility and selective migration of X- and Y-bearing human spermatozoaFertil Steril (1976) 27:407–12  [PubMed]
158. Idaomar M, Guerin JF, Lornage J, Czyba JC. Stimulation of motility and energy metabolism of spermatozoa from asthenozoospermic patients by 17 beta-estradiolArch Androl (1989) 22:197–20210.3109/01485018908986772  [PubMed] [Cross Ref]
159. Mattingly KA, Ivanova MM, Riggs KA, Wickramasinghe NS, Barch MJ, Klinge CM. Estradiol stimulates transcription of nuclear respiratory factor-1 and increases mitochondrial biogenesisMol Endocrinol (2008) 22:609–2210.1210/me.2007-0029 [PMC free article]  [PubMed] [Cross Ref]
160. Adeoya-Osiguwa SA, Markoulaki S, Pocock V, Milligan SR, Fraser LR. 17Beta-estradiol and environmental estrogens significantly affect mammalian sperm functionHum Reprod (2003) 18:100–710.1093/humrep/deg037  [PubMed] [Cross Ref]
161. Ded L, Dostalova P, Dorosh A, Dvorakova-Hortova K, Peknicova J. Effect of estrogens on boar sperm capacitation in vitroReprod Biol Endocrinol (2010) 8:87.10.1186/1477-7827-8-87 [PMC free article][PubMed] [Cross Ref]
162. Carani C, Qin K, Simoni M, Faustini-Fustini M, Serpente S, Boyd J, et al. Effect of testosterone and estradiol in a man with aromatase deficiencyN Engl J Med (1997) 337:91–510.1056/NEJM199707103370204  [PubMed] [Cross Ref]
163. Herrmann BL, Saller B, Janssen OE, Gocke P, Bockisch A, Sperling H, et al. Impact of estrogen replacement therapy in a male with congenital aromatase deficiency caused by a novel mutation in the CYP19 geneJ Clin Endocrinol Metab (2002) 87:5476–8410.1210/jc.2002-020498  [PubMed] [Cross Ref]
164. Maffei L, Murata Y, Rochira V, Tubert G, Aranda C, Vazquez M, et al. Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: effects of testosterone, alendronate, and estradiol treatmentJ Clin Endocrinol Metab (2004) 89:61–7010.1210/jc.2003-030313  [PubMed] [Cross Ref]

Articles from Frontiers in Endocrinology are provided here courtesy of Frontiers Media SA
twin memes II